SGLT2抑制剂:主要文献中糖尿病酮症酸中毒及相关危险因素的系统综述

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Pub Date : 2017-02-01 DOI:10.1002/phar.1881

K. R. Burke, Christine Schumacher, Spencer E. Harpe

{"title":"SGLT2抑制剂:主要文献中糖尿病酮症酸中毒及相关危险因素的系统综述","authors":"K. R. Burke, Christine Schumacher, Spencer E. Harpe","doi":"10.1002/phar.1881","DOIUrl":null,"url":null,"abstract":"Currently only minimal information is available regarding risk factors for the development of sodium glucose cotransporter‐2 inhibitor (SGLT2i)‐related diabetic ketoacidosis (DKA). We aim to identify individual patient characteristics associated with cases of SGLT2i‐related DKA to better describe potential risk factors.","PeriodicalId":19812,"journal":{"name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"153","resultStr":"{\"title\":\"SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature\",\"authors\":\"K. R. Burke, Christine Schumacher, Spencer E. Harpe\",\"doi\":\"10.1002/phar.1881\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Currently only minimal information is available regarding risk factors for the development of sodium glucose cotransporter‐2 inhibitor (SGLT2i)‐related diabetic ketoacidosis (DKA). We aim to identify individual patient characteristics associated with cases of SGLT2i‐related DKA to better describe potential risk factors.\",\"PeriodicalId\":19812,\"journal\":{\"name\":\"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"153\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/phar.1881\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/phar.1881","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 153

摘要

目前，关于葡萄糖共转运蛋白2抑制剂钠(SGLT2i)相关糖尿病酮症酸中毒(DKA)发生的危险因素的信息很少。我们的目标是确定与SGLT2i相关的DKA病例相关的个体患者特征，以更好地描述潜在的危险因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature

Currently only minimal information is available regarding risk factors for the development of sodium glucose cotransporter‐2 inhibitor (SGLT2i)‐related diabetic ketoacidosis (DKA). We aim to identify individual patient characteristics associated with cases of SGLT2i‐related DKA to better describe potential risk factors.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

自引率

0.00%

发文量